Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
As DAB is a carcinogen
MMP9 degrades type IV and V collagens
Mouse ATP1A1 Ready-To-Use IHC Kit
suggesting this pathway may be a useful therapeutic target in inflammatory diseases such as asthma
Anti-human VEGFR1 / FLT1 (Abbott patent Anti-Flt1 Biosimilar) Size:1 mg As DAB is a carcinogenApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGFR1 FLT1 Target Uniprot P17948 Overview Catalog# BIO0411SM Product Name Anti human VEGFR1 FLT1 (Abbott patent Anti Flt1 Biosimilar) Specifications Conjugation None Clone# Abbott patent Anti Flt1 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with
US$ 169.00
US$ 13.99
US$ 17.99
US$ 45.00
US$ 48.00
US$ 104.36
